Legal News

The American Medical Association is urging the FDA to approve OTC access to oral contraceptives.

During COVID-19, pharmacy technicians helped keep immunization programs running.

The bill allows state attorneys general and the Federal Trade Commission the ability to initiate legal action against certain PBM business practices.

The administration also pledged to continue its work with existing pharmacy partners to improve the patient experience.

APhA priorities include pharmacist reimbursement, PBMs, and DIR fees.

Iowa Senator Chuck Grassley is pushing the FTC to investigate PBM practices.

NACDS CEO responds to comments by AMA president.

Without transparency, pharmacy owners must clear numerous hurdles to run an effective business.

Does anxiety justify an exemption from vaccine mandates among health care workers?

Robert M. Califf, MD, MACC, was approved in a 50-46 vote by the senate.

Drug overdoses now cost the United States about $1 trillion annually.

CMS and state officials are using payment incentives, data collection and program requirements to start edging the lofty ideals of health equity toward reality.

Employee mandate would have impacted 84 million workers. Healthcare mandate affects every facility that receives federal funding.

The findings show that increased access to emergency contraception does not compromise use of other more effective methods or lead to an increase in reported levels of unprotected sexual intercourse, according to Hawkins.

Free coverage starts January 15

The NCPA urges pharmacists to send an electronic message to Governor Kathy Hochul to sign 3 pro-pharmacy bills that are currently waiting her signature.

Take a look back at the top 10 legal news articles published on Drug Topics® this year.

On September 28, the FDA granted approval to oral atogepant (Qulipta) for the prevention of migraine.

As we head into 2022, the pharmaceutical industry still faces uncertainty stemming from supply chain challenges.

Collaboration among stakeholders is needed to increase transparency of pharmacy payment programs and to better align the design of these models with good patient care.

Two key health provisions in the House “BBB “ would empower CMS to negotiate the prices of 10 drugs starting in 2023 and put a limit of $2,000 on Medicare Part D annual out-of-pocket costs.

The vaccine mandate applies to employees at facilities that participate in the Medicare and Medicaid insurance programs.

After a panel federal judges put a temporary halt on the mandate, the U.S. Surgeon General says the administration is ready to fight for the requirement.

Pharmacists in 2 states are now empowered to administer FDA approved, CDC recommended vaccines.

In an exclusive interview with Drug Topics, Beth Mitchell, senior director of government affairs at AmerisourceBergen, explores the ways that pharmacists can take action on legislation that affects their practice.

Selling CBD can be profitable for pharmacies, if they follow regulatory guidelines.

AmerisourceBergen and Good Neighbor Pharmacy are working to support policies that will help advance the pharmacy profession.